These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 20970433)

  • 1. Neuraminidase inhibitors for treatment of human and avian strain influenza: A comparative modeling study.
    Dobrovolny HM; Gieschke R; Davies BE; Jumbe NL; Beauchemin CA
    J Theor Biol; 2011 Jan; 269(1):234-44. PubMed ID: 20970433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuraminidase inhibitors and their role in avian and pandemic influenza.
    Crusat M; de Jong MD
    Antivir Ther; 2007; 12(4 Pt B):593-602. PubMed ID: 17944267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixed influenza A and B infections complicate the detection of influenza viruses with altered sensitivities to neuraminidase inhibitors.
    Mohr PG; Geyer H; McKimm-Breschkin JL
    Antiviral Res; 2011 Jul; 91(1):20-2. PubMed ID: 21549758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antivirals and influenza: frequency of resistance.
    Monto AS
    Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S110-2. PubMed ID: 18820569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of neuraminidase inhibitors for the treatment of influenza A virus infections].
    Ferraris O; Escuret V; Bouscambert-Duchamp M; Lina B; Morfin F
    Pathol Biol (Paris); 2010 Apr; 58(2):e69-78. PubMed ID: 20303677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oseltamivir boosts 2009 H1N1 virus infectivity in vitro.
    Lin X; Zhou J; Zhang Y; Wu J; Zhang F; Li Z; Zhang Y; Bi S; Shu Y; Wang Y
    Biochem Biophys Res Commun; 2009 Dec; 390(4):1305-8. PubMed ID: 19879239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus.
    Wang SQ; Du QS; Huang RB; Zhang DW; Chou KC
    Biochem Biophys Res Commun; 2009 Aug; 386(3):432-6. PubMed ID: 19523442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of neuraminidase inhibitors to combat pandemic influenza.
    Democratis J; Pareek M; Stephenson I
    J Antimicrob Chemother; 2006 Nov; 58(5):911-5. PubMed ID: 16956904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neuraminidase inhibitors in prophylaxis and treatment of influenza].
    Nitsch-Osuch A; Brydak LB; Wardyn AK
    Pol Merkur Lekarski; 2008 Jul; 25(145):67-73. PubMed ID: 18839619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The in vivo efficacy of neuraminidase inhibitors cannot be determined from the decay rates of influenza viral titers observed in treated patients.
    Palmer J; Dobrovolny HM; Beauchemin CA
    Sci Rep; 2017 Jan; 7():40210. PubMed ID: 28067324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epidemiology, clinical picture, prevention and treatment of Avian influenza].
    Angelava NA; Angelava AV
    Georgian Med News; 2006 Feb; (131):69-76. PubMed ID: 16575138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid quantitation of neuraminidase inhibitor drug resistance in influenza virus quasispecies.
    Lackenby A; Democratis J; Siqueira MM; Zambon MC
    Antivir Ther; 2008; 13(6):809-20. PubMed ID: 18839782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons.
    Kawai N; Ikematsu H; Hirotsu N; Maeda T; Kawashima T; Tanaka O; Yamauchi S; Kawamura K; Matsuura S; Nishimura M; Iwaki N; Kashiwagi S
    Clin Infect Dis; 2009 Dec; 49(12):1828-35. PubMed ID: 19911968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early therapy with the neuraminidase inhibitor oseltamivir maximizes its efficacy in influenza treatment.
    Gillissen A; Höffken G
    Med Microbiol Immunol; 2002 Dec; 191(3-4):165-8. PubMed ID: 12458353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug resistance. A 'wimpy' flu strain mysteriously turns scary.
    Enserink M
    Science; 2009 Feb; 323(5918):1162-3. PubMed ID: 19251605
    [No Abstract]   [Full Text] [Related]  

  • 17. Selection and viral load kinetics of an oseltamivir-resistant pandemic influenza A (H1N1) virus in an immunocompromised patient during treatment with neuraminidase inhibitors.
    Antón A; López-Iglesias AA; Tórtola T; Ruiz-Camps I; Abrisqueta P; Llopart L; Marcos MÁ; Martínez MJ; Tudó G; Bosch F; Pahissa A; de Anta MT; Pumarola T
    Diagn Microbiol Infect Dis; 2010 Nov; 68(3):214-9. PubMed ID: 20955912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral management of seasonal and pandemic influenza.
    Hayden FG; Pavia AT
    J Infect Dis; 2006 Nov; 194 Suppl 2():S119-26. PubMed ID: 17163384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance of the neuraminidase inhibitor oseltamivir for the management of seasonal influenza].
    Ruf BR; Sandow P; Lehmann P; Del Piero L; Skopnik H
    Dtsch Med Wochenschr; 2008 Jun; 133(23):1259-64. PubMed ID: 18509804
    [No Abstract]   [Full Text] [Related]  

  • 20. [Neuraminidase inhibitors in therapy of influenza].
    Fladerer P; Wenisch C
    Acta Med Austriaca; 2000; 27(5):133-40. PubMed ID: 11261262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.